# Regulus search export - Query: `82 FR 52229` - Source type: All - Part: All - Source: All - Status: All - Jurisdiction: All - Collection: All - Incident class: All - Sort: relevance - Date from: Any - Date to: Any - As of: Current corpus - Results: 1 - Exported: 2026-08-23T15:51:58.059Z ## 1. Procedures for Transportation Workplace Drug and Alcohol Testing Programs: Addition of Certain Schedule II Drugs to the Department of Transportation's Drug-Testing Panel and Certain Minor Amendments **Citation:** 82 FR 52229 **Type / status:** rulemaking / historical **Agency:** Office of the Secretary **Effective / published:** 2018-01-01 / 2017-11-13 The Department of Transportation is amending its drug-testing program regulation to add hydrocodone, hydromorphone, oxymorphone, and oxycodone to its drug-testing panel; add methylenedioxyamphetamine as an initial test analyte; and remove methylenedioxyethylamphetamine as a confirmatory test analyte. The revision of the drug-testing panel harmonizes DOT regulations with the revised HHS Mandatory Guidelines established by the U.S. Department of Health and Human Services for Federal drug-testing programs for urine testing. This final rule clarifies certain existing drug-testing program provisions and definitions, makes technical amendments, and removes the requirement for employers and Consortium/Third Party Administrators to submit blind specimens. ### Provenance - Official: Yes - Source: - Source ID: `federal-register` - SHA-256: `95f86f3ca293a9cd579f183c3ed794fa6a46780dec824b0c0f6cf8c742fcd2b5` - Retrieved: 2026-08-20T06:04:51.294Z - Document slug: `federal-register-2017-24397` - Related records: 43